Earnings Feed
Start Free
Akari Therapeutics Plc·4

Dec 30, 4:30 PM ET

Patel Samir Rashmikant 4

4 · Akari Therapeutics Plc · Filed Dec 30, 2024

Insider Transaction Report

Form 4
Period: 2024-12-26
Akari Therapeutics PlcAKTX
Patel Samir Rashmikant
Director
Transactions
  • Award

    Ordinary Shares, par value $0.0001 per share

    2024-12-27$0.00/sh+400,000$200→ 5,249,303,500 total(indirect: By LLC)
  • Award

    Ordinary Shares, par value $0.0001 per share

    2024-12-26$0.00/sh+3,200,000$1,600→ 5,248,903,500 total(indirect: By LLC)
Holdings

  • Ordinary Shares, par value $0.0001 per share

    91,396,000
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
  • [F2]On December 26, 2024, the Reporting Person acquired 3,200,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.
  • [F3]On December 27, 2024 the Reporting Person acquired 400,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4